|
Model Number M00516210 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Dysphagia/ Odynophagia (1815)
|
Event Date 01/17/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
Block h6: imdrf patient code e1009 captures the reportable event of dysphagia.Imdrf impact code f2301 is being used to capture the removal of the stent.
|
|
Event Description
|
Note: this report pertains to one of three devices used in the same patient.Refer to manufacturer reports # 3005099803-2023-06204, 3005099803-2024-00099 for the associated device information.It was reported to boston scientific corporation that a wallflex fully covered esophageal stent was implanted on (b)(6) 2023, in the middle esophagus to address a persistent dysphagia after two previously implanted agile esophageal stents performed (b)(6) 2023 respectively.The patient's anatomy was tortuous.On (b)(6) 2023, the patient was implanted with an agile esophageal partially covered stent (the subject of mfr.Report # 3005099803-2024-00099) to treat a malignant stricture; however, on (b)(6) 2023, the patient presented with dysphagia prompting the physician to check the stent.Stent ingrowth was observed, and the stent was repositioned.On (b)(6) 2023, the patient again experienced dysphagia, thus, a second agile esophageal stent (the subject of mfr.Report # 3005099803-2023-06204) was implanted.Subsequently, on (b)(6) 2023, the patient again presented with dysphagia which physician then observed a stent ingrowth.A wallflex esophageal stent (the subject of this report) was then implanted to restore patency.On (b)(6) 2024, the patient presented with dysphagia for the fourth time, thus, consequently, both the second agile and the wallflex esophageal stents were removed.A non-boston scientific stent was then placed stent-in-stent on the uncovered portion of the first agile esophageal stent.
|
|
Manufacturer Narrative
|
Block h6: imdrf patient code e1009 captures the reportable event of dysphagia.Imdrf impact code f2301 is being used to capture the removal of the stent.Block h11: correction to the initial mdr in block h6 (impact codes).
|
|
Event Description
|
Note: this report pertains to one of three devices used in the same patient.Refer to manufacturer reports # 3005099803-2023-06204, 3005099803-2024-00099, and 3005099803-2024-01133 for the associated device information.It was reported to boston scientific corporation that a wallflex fully covered esophageal stent was implanted on (b)(6) 2023, in the middle esophagus to address a persistent dysphagia after two previously implanted agile esophageal stents performed (b)(6)2023 and (b)(6) 2023 respectively.The patient's anatomy was tortuous.On (b)(6) 2023, the patient was implanted with an agile esophageal partially covered stent (the subject of mfr.Report # 3005099803-2024-00099) to treat a malignant stricture; however, on (b)(6) 2023, the patient presented with dysphagia prompting the physician to check the stent.Stent ingrowth was observed, and the stent was repositioned.On (b)(6) 2023, the patient again experienced dysphagia, thus, a second agile esophageal stent (the subject of mfr.Report # 3005099803-2023-06204) was implanted.Subsequently, on (b)(6) 2023, the patient again presented with dysphagia which physician then observed a stent ingrowth.A wallflex esophageal stent (the subject of this report) was then implanted to restore patency.On (b)(6) 2024, the patient presented with dysphagia for the fourth time, thus, consequently, both the second agile and the wallflex esophageal stents were removed.A non-boston scientific stent was then placed stent-in-stent on the uncovered portion of the first agile esophageal stent.
|
|
Search Alerts/Recalls
|
|
|